Di Lena M

No ORCID on file · 1 paper in corpus
2018
Mirabegron as adjuvant treatment for patients with interstitial cystitis/bladder pain syndrome.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada ·doi:10.5489/cuaj.4325

IntroductionInterstitial cystitis/bladder pain syndrome (IC/BPS) patients represent a heterogeneous group with pain and urinary storage symptoms and varying responses to current treatment options. The novel beta-3 agonist, mirabegron, has b…